Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People With Multiple Food Allergies
February 26, 2024
February 26, 2024
BALTIMORE, Maryland, Feb. 26 (TNSres) -- Johns Hopkins Medicine issued the following news release:
* * *
Results suggest omalizumab has the potential to be a 'life-changing' medication for patients with food allergy, including those with multiple food allergies
* * *
A study led by Johns Hopkins Children's Center shows omalizumab -- an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and othe . . .
* * *
Results suggest omalizumab has the potential to be a 'life-changing' medication for patients with food allergy, including those with multiple food allergies
* * *
A study led by Johns Hopkins Children's Center shows omalizumab -- an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and othe . . .